- Home
- CFLT vs CORT Comparison
CFLT vs CORT Comparison
Compare CFLT & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CFLT
- CORT
- Stock Information
- Founded
- CFLT 2014
- CORT 1998
- Country
- CFLT United States
- CORT United States
- Employees
- CFLT N/A
- CORT N/A
- Industry
- CFLT EDP Services
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- CFLT Technology
- CORT Health Care
- Exchange
- CFLT Nasdaq
- CORT Nasdaq
- Market Cap
- CFLT 8.5B
- CORT 7.5B
- IPO Year
- CFLT 2021
- CORT N/A
- Fundamental
- Price
- CFLT $24.11
- CORT $71.72
- Analyst Decision
- CFLT Buy
- CORT Strong Buy
- Analyst Count
- CFLT 30
- CORT 4
- Target Price
- CFLT $31.07
- CORT $142.00
- AVG Volume (30 Days)
- CFLT 5.4M
- CORT 1.6M
- Earning Date
- CFLT 07-30-2025
- CORT 07-28-2025
- Dividend Yield
- CFLT N/A
- CORT N/A
- EPS Growth
- CFLT N/A
- CORT 8.36
- EPS
- CFLT N/A
- CORT 1.14
- Revenue
- CFLT $1,017,525,000.00
- CORT $685,446,000.00
- Revenue This Year
- CFLT $21.52
- CORT $35.83
- Revenue Next Year
- CFLT $18.27
- CORT $35.24
- P/E Ratio
- CFLT N/A
- CORT $62.92
- Revenue Growth
- CFLT 24.11
- CORT 30.93
- 52 Week Low
- CFLT $17.79
- CORT $30.77
- 52 Week High
- CFLT $37.90
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- CFLT 50.43
- CORT 50.50
- Support Level
- CFLT $23.88
- CORT $66.49
- Resistance Level
- CFLT $26.70
- CORT $72.49
- Average True Range (ATR)
- CFLT 0.92
- CORT 2.85
- MACD
- CFLT -0.07
- CORT -0.09
- Stochastic Oscillator
- CFLT 43.37
- CORT 49.95
About CFLT Confluent Inc.
Confluent Inc provides a data streaming platform that enables customers to connect their applications, systems, and data layers and can be deployed as a fully managed cloud-native software-as-a-service (SaaS) offering. Its products include Confluent Cloud, a self-managed software offering, Confluent Platform, a managed service offering where the raw data resides inside a customer's cloud environment, and WarpStream, among others. Confluent also offers professional services and education services. The company generates revenue from the sale of subscriptions and services. Geographically, it generates a majority of its revenue from its business in the United States and the rest from International markets.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.